American Journal of Obstetrics & Gynecology
Volume 189, Issue 1 , Pages 274-279 , July 2003

Longitudinal analysis of serum insulin-like growth factor-I and insulin-like growth factor binding protein-1 in antiphospholipid syndrome and in healthy pregnancy

  • Sophia Stone, MBBS

      Affiliations

    • From the Departments of Maternal and Fetal Research Unit and Women's Health, Guy's, King's and St Thomas' School of Medicine, King's College London, United Kingdom
    • the Lupus Pregnancy Clinic London, United Kingdom
    • ,
  • Kate Langford, MD

      Affiliations

    • and the Fetal Medicine Unit London, United Kingdom
    • ,
  • Paul T. Seed, MSc, CStat

      Affiliations

    • From the Departments of Maternal and Fetal Research Unit and Women's Health, Guy's, King's and St Thomas' School of Medicine, King's College London, United Kingdom
    • ,
  • Munther A. Khamashta, MD

      Affiliations

    • the Lupus Pregnancy Clinic London, United Kingdom
    • ,
  • Beverley J. Hunt, MD

      Affiliations

    • the Lupus Pregnancy Clinic London, United Kingdom
    • and the Department of Haematology, Guy's and St Thomas' Hospitals Trust. London, United Kingdom
    • ,
  • Lucilla Poston, PhD

      Affiliations

    • From the Departments of Maternal and Fetal Research Unit and Women's Health, Guy's, King's and St Thomas' School of Medicine, King's College London, United Kingdom

Received 16 October 2002 ,Revised 18 December 2002 ,Accepted 28 March 2003.

References 

  1. Stone S, Hunt BJ, Seed PT, Parmar K, Khamashta MA, Poston L. Longitudinal evaluation of markers of endothelial cell dysfunction and hemostasis in treated antiphospholipid syndrome and in healthy pregnancy. Am J Obstet Gynecol. 2003;188:454–460
  2. Magid MS, Kaplan C, Sammaritano LR, Peterson M, Druzin ML, Lockshin MD. Placental pathology in systemic lupus erythematosus: a prospective study. Am J Obstet Gynecol. 1998;179:226–234
  3. Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L, et al.  Placental bed spiral arteries in the hypertensive disorders of pregnancy. BJOG. 1991;98:648–655
  4. Giudice LC, Martina NA, Crystal RA, Tazuke S, Druzin M. Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia. Am J Obstet Gynecol. 1997;176:751–758
  5. Gratton RJ, Asano H, Han VK. The regional expression of insulin-like growth factor II (IGF-II) and insulin-like growth factor binding protein-1 (IGFBP-1) in the placentae of women with pre-eclampsia. Placenta. 2002;23:303–310
  6. Anim-Nyame N, Hills FA, Sooranna SR, Steer PJ, Johnson MR. A longitudinal study of maternal plasma insulin-like growth factor binding protein-1 concentrations during normal pregnancy and pregnancies complicated by pre-eclampsia. Hum Reprod. 2000;15:2215–2219
  7. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al.  International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum. 1999;42:1309–1311
  8. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 1988;158:892–898
  9. Gardosi J, Chang A, Kalyan B, Sahota D, Symonds EM. Customized antenatal growth charts. Lancet. 1992;339:283–287
  10. Hunt BJ, Doughty H, Majurndar G, Copplestone A, Kerslake S, Buchanan N, et al.  Thromboprophylaxis with low molecular weight heparin (fragmin) in high risk pregnancies. Thromb Haemost. 1997;77:39–43
  11. Hunt BJ, Khamashta MA, Lakasing L, Williams FMK, Nelson Piercy C, Bewley S, et al.  Thromboprophylaxis in antiphospholipid syndrome pregnancies with previous cerebral arterial thrombotic events: is warfarin preferable?. Thromb Haemost. 1998;79:1060–1061
  12. Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, et al.  Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 1983;2:1211–1214
  13. Liang K-Y, Zeger SL. Longitudinal analysis using generalised linear models. Biometrika. 1986;73:13–22
  14. Langford K, Blum W, Nicolaides K, Jones J, McGregor A, Miell J. The pathophysiology of the insulin-like growth factor axis in fetal growth failure: a basis for programming by undernutrition?. Eur J Clin Invest. 1994;24:851–856
  15. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol. 1992;80:614–620
  16. Di Simone N, Del Papa N, Raschi E, Caliandro D, De Carolis S, Khamashta MA, et al.  Antiphospholipid antibodies affect trophoblast gonadotrophin secretion and invasiveness by binding directly and through adhered β2-glycoprotein I. Arthritis Rheum. 2000;43:140–150
  17. Chamley LW, Duncalf AM, Mitchell MD, Johnson PM. Action of anticardiolipin and antibodies to β2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death. Lancet. 1998;352:1037–1038
  18. Bhatia S, Faessen GH, Carland G, Balise RL, Gargosky SE, Druzin M, et al.  A longitudinal analysis of maternal serum insulin-like growth factor I (IGF-I) and total and nonphosphorylated IGF-binding protein-1 in human pregnancies complicated by intrauterine growth restriction. J Clin Endocrinol Metab. 2002;87:1864–1870
  19. Hietala R, Pohja-Nylander P, Rutanen EM, Laatikainen T. Serum insulin-like growth factor binding protein-1 at 16 weeks and subsequent preeclampsia. Obstet Gynecol. 2000;95:185–189
  20. Grobman WA, Kazer RR. Serum insulin, insulin-like growth factor-I, and insulin-like growth factor binding protein-1 in women who develop preeclampsia. Obstet Gynecol. 2001;97:521–526
  21. Sheikh S, Satoskar P, Bhartiya D. Expression of insulin-like growth factor-I and placental growth hormone mRNA in placentae: a comparison between normal and intrauterine growth retardation pregnancies. Mol Hum Reprod. 2001;7:287–292
  22. Hamilton GF, Lysiak JJ, Han VKM, Lala PK. Autocrine-paracrine regulation of human trophoblast invasiveness by insulin-like growth factor (IGF)-II and IGF-binding protein (IGFBP)-1. Exp Cell Res. 1998;244:147–156
  23. Tazuke SI, Mazure NM, Sugawara J, Carland G, Faessen GH, Suen LF, et al.  Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. Proc Natl Acad Sci U S A. 1998;95:10188–10193
  24. Langford K, Nicolaides K, Miell JP. Maternal and fetal insulin-like growth factors and their binding proteins in the second and third trimesters of human pregnancy. Hum Reprod. 1998;13:1389–1393
  25. Holmes R, Porter H, Newcomb P, Holly JMP, Soothill P. An immunohistochemical study of type I insulin-like growth factor receptors in the placentae of pregnancies with appropriately grown or growth restricted fetuses. Placenta. 1999;20:325–330

☆ Supported by Tommy's the Baby Charity and Lupus UK.

☆☆ Reprint requests: L. Poston, PhD, Maternal and Fetal Research Unit, 10th Floor North Wing, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, United Kingdom. E-mail: lucilla.poston@kcl.ac.uk

PII: S0002-9378(03)00472-1

doi: 10.1067/mob.2003.486

American Journal of Obstetrics & Gynecology
Volume 189, Issue 1 , Pages 274-279 , July 2003

Article Tools

* Image Usage & Resolution